| Title |
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
|
|---|---|
| Published in |
Genome Medicine, March 2018
|
| DOI | 10.1186/s13073-018-0531-8 |
| Pubmed ID | |
| Authors |
David Tamborero, Carlota Rubio-Perez, Jordi Deu-Pons, Michael P. Schroeder, Ana Vivancos, Ana Rovira, Ignasi Tusquets, Joan Albanell, Jordi Rodon, Josep Tabernero, Carmen de Torres, Rodrigo Dienstmann, Abel Gonzalez-Perez, Nuria Lopez-Bigas |
X Demographics
The data shown below were collected from the profiles of 57 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 14% |
| Spain | 5 | 9% |
| United Kingdom | 5 | 9% |
| Ecuador | 3 | 5% |
| Sweden | 2 | 4% |
| Mexico | 2 | 4% |
| Austria | 2 | 4% |
| Egypt | 1 | 2% |
| India | 1 | 2% |
| Other | 12 | 21% |
| Unknown | 16 | 28% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 29 | 51% |
| Members of the public | 26 | 46% |
| Science communicators (journalists, bloggers, editors) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 403 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Germany | 1 | <1% |
| Unknown | 401 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 87 | 22% |
| Student > Ph. D. Student | 78 | 19% |
| Student > Bachelor | 36 | 9% |
| Student > Master | 35 | 9% |
| Other | 24 | 6% |
| Other | 51 | 13% |
| Unknown | 92 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 144 | 36% |
| Agricultural and Biological Sciences | 47 | 12% |
| Medicine and Dentistry | 44 | 11% |
| Computer Science | 27 | 7% |
| Engineering | 7 | 2% |
| Other | 29 | 7% |
| Unknown | 105 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 44. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 December 2022.
All research outputs
#962,941
of 26,017,215 outputs
Outputs from Genome Medicine
#185
of 1,612 outputs
Outputs of similar age
#21,345
of 348,171 outputs
Outputs of similar age from Genome Medicine
#5
of 25 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,612 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.8. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 348,171 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.